MK Proteins IPO is a Fixed Price listing on NSE EMERGE exchange, with an ipo size of ₹ 10.23 Cr. The company is based in Ambala and caters to Agro - Food Products sector. Sarthi Capital Advisors is the merchant banker of MK Proteins IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 7th March 2017.
MK Proteins IPO posted revenues of ₹ 147.91 Cr. and PAT of ₹ 0.55 Cr. in FY17 on annualised basis.Financial results of MK Proteins IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Dec-16 | FY16 | FY15 | FY14 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 42.45 | 38.78 | 35.05 | 32.04 | |
Net Worth | 3.67 | 3.26 | 2.53 | 1.70 | |
Total Debt | 19.10 | 25.87 | 19.60 | 27.82 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
110.93
147.91 |
144.75 | 123.23 | 121.73 | |
EBITDA
EBITDA on annualised basis |
3.00
4.00 |
4.27 | 4.16 | 2.80 | |
PAT
PAT on annualised basis |
0.41
0.55 |
0.72 | 0.83 | 0.49 |
MK Proteins IPO PAT Margin is 0.37 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows MK Proteins IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Dec-16 | FY16 | FY15 | FY14 |
---|---|---|---|---|
EBITDA Margin (%) | 2.70 | 2.95 | 3.38 | 2.30 |
PAT Margin (%) | 0.37 | 0.50 | 0.67 | 0.40 |
EPS (₹) | 1.53 | 2.67 | 3.09 | 1.82 |
ROE (%) | 11.17 | 22.09 | 32.81 | 28.82 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 0.97 | 1.86 | 2.37 | 1.53 |
Debt to Equity | 5.20 | 7.94 | 7.75 | 16.36 |
The market Capitalisation of MK Proteins IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The MK Proteins IPO prospectus highlights an Return on Equity (ROE) of 11.17 % , Return on Assets (ROA) of 0.97 %, and an EBITDA Margin of 2.70 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows MK Proteins IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of MK Proteins IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The MK Proteins IPO has a Price-to-Earnings (PE) ratio of 53.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
MK Proteins IPO reported revenue of ₹ 147.97 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from MK Proteins IPO provide insights into sales growth, market demand, and business scalability.
MK Proteins recorded an EBITDA of ₹ 4.00 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
MK Proteins Profit After Tax (PAT) is ₹ 0.55 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
MK Proteins operates in Agro - Food Products and Manufacturing And Trading Organization Having Its Production Refining Plant Of Edible Oils. The Issue is listed on NSE EMERGE in Apr, 2017. MK Proteins IPO size was 10.23 with Issue price of 70.00 .
Merchant Banker(s) of MK Proteins IPO: Sarthi Capital Advisors Private Limited
MK Proteins IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
MK Proteins IPO listed at a listing price of 72.00 against the offer price of 70.00.
The current market price of MK Proteins is 7.27.
Why Us?